9 Comments

Why has the FDA not updated its regulations to comply with the new laws passed by Congress? Is it that special interests connected to Big Pharma are delaying its implementation? Or is there a large business concern which "supplies animals" to labs? Or both.

Expand full comment
author

I think you are on to something, Perry! It's hard to imagine any legitimate reason, isn't it?

Expand full comment

It is a bigger business that I originally thought. For those interested, here is a link to a long list of official U.S. suppliers of lab animals. It is from the National Library of Medicine:

https://www.ncbi.nlm.nih.gov/books/NBK234030/

Expand full comment
Sep 16Liked by Ed Boks

Yes, providing animals for research is a big business. One most people never hear about.

Expand full comment
Sep 16Liked by Ed Boks

This bill getting bi-partisan support is great news! BTW, the Physicians Committee for Responsible Medicine has been advocating for this for years, as well as advocating a vegan diet. Their public statements focus more on benefits for humans (the only way to "sell" the message to most of the public), but I know that compassion for animals is a big concern for them.

Expand full comment
author

Jan, it's wonderful to hear your enthusiasm for the FDA Modernization Act 3.0! True, the PCRM dedication to both human health and animal welfare is commendable, and it's great to see their efforts aligning with this legislative push. It's an exciting time for those who care about both scientific innovation and compassion for animals.

Expand full comment

“An overwhelming 90-95% of drugs that succeed in animal trials fail in human clinical settings.”

I suppose this data point could be flawed, and I’m certainly biased, but it’s hard to imagine any human being contesting this.

Expand full comment
author

Damon, thank you for sharing your thoughts on the data point regarding the failure rate of drugs that succeed in animal trials. It's understandable to question such statistics, especially when they highlight such significant inefficiencies. While it's true that data can be complex and subject to interpretation, this particular statistic underscores a widely recognized challenge in drug development. Many experts and organizations advocate for modernizing testing methods to improve accuracy and efficiency, which is exactly what the FDA Modernization Act 3.0 aims to address. It's an exciting time as we finally move toward more innovative and humane approaches in science.

Expand full comment

I'm here for all that. Thank you, Ed.

Expand full comment